FI894615A - Menetelmä valmistaa farmakologisesti arvokasta pteridiiniä - Google Patents

Menetelmä valmistaa farmakologisesti arvokasta pteridiiniä Download PDF

Info

Publication number
FI894615A
FI894615A FI894615A FI894615A FI894615A FI 894615 A FI894615 A FI 894615A FI 894615 A FI894615 A FI 894615A FI 894615 A FI894615 A FI 894615A FI 894615 A FI894615 A FI 894615A
Authority
FI
Finland
Prior art keywords
group
pteridines
pteridine
preparation
substituted
Prior art date
Application number
FI894615A
Other languages
English (en)
Swedish (sv)
Other versions
FI92699C (fi
FI894615A0 (fi
FI92699B (fi
Inventor
Armin Heckel
Joerg Lebsanft
Uwe Bamberger
Avner Ramu
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI894615A0 publication Critical patent/FI894615A0/fi
Publication of FI894615A publication Critical patent/FI894615A/fi
Application granted granted Critical
Publication of FI92699B publication Critical patent/FI92699B/fi
Publication of FI92699C publication Critical patent/FI92699C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI894615A 1988-10-01 1989-09-29 Menetelmä valmistaa farmakologisesti arvokasta pteridiiniä FI92699C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3833393A DE3833393A1 (de) 1988-10-01 1988-10-01 Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel
DE3833393 1988-10-01

Publications (4)

Publication Number Publication Date
FI894615A0 FI894615A0 (fi) 1989-09-29
FI894615A true FI894615A (fi) 1990-04-02
FI92699B FI92699B (fi) 1994-09-15
FI92699C FI92699C (fi) 1994-12-27

Family

ID=6364156

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894615A FI92699C (fi) 1988-10-01 1989-09-29 Menetelmä valmistaa farmakologisesti arvokasta pteridiiniä

Country Status (19)

Country Link
EP (1) EP0362645B1 (fi)
JP (1) JPH02256676A (fi)
KR (1) KR910006289A (fi)
AT (1) ATE106728T1 (fi)
AU (1) AU620645B2 (fi)
DD (1) DD299062A5 (fi)
DE (2) DE3833393A1 (fi)
DK (1) DK480489A (fi)
ES (1) ES2056174T3 (fi)
FI (1) FI92699C (fi)
HU (1) HU205761B (fi)
IL (1) IL91814A (fi)
MX (1) MX9203034A (fi)
NO (1) NO175979C (fi)
NZ (1) NZ230833A (fi)
PT (1) PT91836B (fi)
SU (1) SU1720491A3 (fi)
UA (1) UA8028A1 (fi)
ZA (1) ZA897414B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000039129A1 (en) * 1998-12-28 2000-07-06 K.U. Leuven Research & Development Immunosuppressive effects of pteridine derivatives
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
WO2005025574A2 (en) * 2003-09-12 2005-03-24 4 Aza Bioscience Nv PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES.
WO2005039587A1 (en) * 2003-10-17 2005-05-06 4 Aza Bioscience Nv Heterocycle-substituted pteridine derivatives and their use in therapy
RU2447074C2 (ru) * 2005-05-12 2012-04-10 Тиботек Фармасьютикалз Лтд. Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
EP3722297A1 (en) 2015-03-04 2020-10-14 Gilead Sciences, Inc. Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
KR20160003575A (ko) 2015-11-09 2016-01-11 정민시 발전기용 동력전달장치
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
AU2017318601B2 (en) 2016-09-02 2020-09-03 Gilead Sciences, Inc. Toll like receptor modulator compounds
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574206A (en) * 1965-04-15 1971-04-06 Boehringer Sohn Ingelheim 2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (fi) * 1966-10-14
DE1617336C2 (de) * 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Arzneimittel gegen Angina pectoris
DE1795515A1 (de) * 1967-08-18 1972-03-30 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Pteridinen
DE1795516A1 (de) * 1967-12-15 1972-01-27 Thomae Gmbh Dr K 4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin
DE1921308A1 (de) * 1969-04-25 1971-01-07 Boehringer Sohn Ingelheim Herzwirksame Zubereitungen
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

Also Published As

Publication number Publication date
PT91836B (pt) 1995-07-18
HU205761B (en) 1992-06-29
EP0362645A3 (de) 1992-03-25
DD299062A5 (de) 1992-03-26
PT91836A (pt) 1990-04-30
MX9203034A (es) 1992-07-01
NO893879D0 (no) 1989-09-29
AU620645B2 (en) 1992-02-20
NZ230833A (en) 1991-05-28
ATE106728T1 (de) 1994-06-15
HUT52504A (en) 1990-07-28
FI92699C (fi) 1994-12-27
DK480489A (da) 1990-04-02
FI894615A0 (fi) 1989-09-29
ES2056174T3 (es) 1994-10-01
FI92699B (fi) 1994-09-15
DE58907824D1 (de) 1994-07-14
IL91814A (en) 1994-02-27
DE3833393A1 (de) 1990-04-05
NO893879L (no) 1990-04-02
EP0362645B1 (de) 1994-06-08
UA8028A1 (uk) 1995-12-26
JPH02256676A (ja) 1990-10-17
NO175979C (no) 1995-01-11
NO175979B (no) 1994-10-03
EP0362645A2 (de) 1990-04-11
SU1720491A3 (ru) 1992-03-15
ZA897414B (en) 1991-06-26
KR910006289A (ko) 1991-04-29
IL91814A0 (en) 1990-06-10
DK480489D0 (da) 1989-09-29
AU4174989A (en) 1990-04-05

Similar Documents

Publication Publication Date Title
FI92699C (fi) Menetelmä valmistaa farmakologisesti arvokasta pteridiiniä
DE19775091I2 (de) Therapeutische heterocyclische Verbindungen
ES8707238A1 (es) Procedimiento para preparar pteridinas
ES390924A1 (es) Procedimiento para la preparacion de derivados del acido nicotinico.
ES463803A1 (es) Procedimiento para la produccion de hidroxilaminas o-alqui- ladas.
GB1389504A (en) 2-amino-1,4-dihydropyridines their production and their medicinal use
ES453276A1 (es) Procedimiento para la preparacion de nuevos derivados de i- midazol y tetrazol.
ES345993A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
ES345991A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
GB1320548A (en) Nitrofurylaminoalkoxy-pyrimidines
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
GB1085922A (en) Improvements in and relating to therapeutic compositions containing 2-amino-oxazolin-4-one derivatives, novel derivatives of this type and process for preparing same
ES422737A1 (es) Procedimiento para la obtencion de compuestos heterocicli- cos a base de piperazina u homopiperazina.
GB1341170A (en) Alkyl sulphonic acid esters of 1,3,2-oxazaphospha-cyclic compounds
ES304710A1 (es) Procedimiento para la preparaciën de 1,3,5-triacinas
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
GB1157246A (en) Dibenzothiepin Derivatives and their preparation
TH9137EX (th) สารประกอบเททราไซคลิคชนิดใหม่ซึ่งมีฤทธิ์ในการต่อต้านภูมิแพ้และต่อต้านโรคหืด การเตรียมและใช้สารเหล่านี้
TH9137A (th) สารประกอบเททราไซคลิคชนิดใหม่ซึ่งมีฤทธิ์ในการต่อต้านภูมิแพ้และต่อต้านโรคหืด การเตรียมและใช้สารเหล่านี้

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: DR. KARL THOMAE GESELLSCHAFT MIT